Growth Metrics

Biomarin Pharmaceutical (BMRN) Amortizatization of Intangibles (2016 - 2026)

Biomarin Pharmaceutical's Amortizatization of Intangibles history spans 17 years, with the latest figure at $1.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles fell 35.92% year-over-year to $1.1 million, compared with a TTM value of $4.8 million through Dec 2025, down 42.47%, and an annual FY2025 reading of $4.8 million, down 42.47% over the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $1.1 million at Biomarin Pharmaceutical, up from $978000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $2.6 million in Q2 2023, with the low at -$1.9 million in Q4 2021.
  • Average Amortizatization of Intangibles over 5 years is $708800.0, with a median of $1.2 million recorded in 2025.
  • Year-over-year, Amortizatization of Intangibles tumbled 5577.27% in 2021 and then soared 435.02% in 2023.
  • Tracing BMRN's Amortizatization of Intangibles over 5 years: stood at -$1.9 million in 2021, then surged by 137.21% to $698000.0 in 2022, then soared by 250.57% to $2.4 million in 2023, then dropped by 29.46% to $1.7 million in 2024, then crashed by 35.92% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for BMRN's Amortizatization of Intangibles are $1.1 million (Q4 2025), $978000.0 (Q3 2025), and $1.4 million (Q2 2025).